Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2020
Net income (loss)		$ 1,158		$ 1,769		$ 701
Depreciation and Amortization		1,223		1,243		1,177
Provision for (Benefit from) Deferred Income Tax		(286)		174		(330)
Net periodic pension and OPEB benefit, net		(142)		(1,292)		(340)
Pension and OPEB contributions		182		247		269
Net gain on sales of property, businesses, consolidated companies, and investments		(18)		(21)		3
Restructuring and asset related charges- net		363		289		335
Other net loss		305		156		290
Accounts and Notes Receivable		(997)		(113)		187
Inventories		(1,715)		(422)		104
Accounts Payable		807		524		(118)
Deferred Revenue		194		574		71
Other Assets and Liabilities, Net		162		93		253
Cash provided by (used for) operating activities		872		2,727		2,064
Capital expenditures		(605)		(573)		(475)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		73		75		83
Escrow funding associated with acquisitions		(36)		0		0
Investments in and loans to nonconsolidated affiliates		(12)		(4)		(1)
Purchases of investments		(344)		(204)		(995)
Proceeds from Sale and Maturities of Investments		295		345		721
Other investing activities - net		(3)		(1)		(7)
Cash provided by (used for) investing activities		(632)		(362)		(674)
Net Change in borrowings (less than 90 days)		(13)		13		0
Proceeds from Debt		1,358		419		2,439
Payments on Debt		(1,140)		(421)		(1,441)
Repurchase of Common Stock		(1,000)		(950)		(275)
Proceeds from Exercise of Stock Options		88		100		56
Dividends Paid to stockholders		(418)		(397)		(388)
Payment for acquisition of subsidiary's interest from the non-controlling interest		0		0		(60)
Other financing activities		(55)		(30)		(28)
Cash provided by (used for) financing activities		(1,180)		(1,266)		303
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents		(278)		(136)		7
Increase (decrease) on cash, cash equivalents and restricted cash		(1,218)		963		1,700
Cash, cash equivalents and restricted cash equivalents at beginning of period		4,836	[1]	3,873	[1]	2,173
Cash, cash equivalents and restricted cash equivalents at end of period	[1]	3,618		4,836		3,873
Interest, net of amounts capitalized		75		30		36
Income Taxes		467		341		229
EIDP
Net income (loss)		1,124		1,731		625
Depreciation and Amortization		1,223		1,243		1,177
Provision for (Benefit from) Deferred Income Tax		(286)		174		(330)
Net periodic pension and OPEB benefit, net		(142)		(1,292)		(340)
Pension and OPEB contributions		182		247		269
Net gain on sales of property, businesses, consolidated companies, and investments		(18)		(21)		3
Restructuring and asset related charges- net		363		289		335
Other net loss		305		156		290
Accounts and Notes Receivable		(997)		(113)		187
Inventories		(1,715)		(422)		104
Accounts Payable		807		524		(118)
Deferred Revenue		194		574		71
Other Assets and Liabilities, Net		163		93		251
Cash provided by (used for) operating activities		839		2,689		1,986
Capital expenditures		(605)		(573)		(475)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested		73		75		83
Escrow funding associated with acquisitions		(36)		0		0
Investments in and loans to nonconsolidated affiliates		(12)		(4)		(1)
Purchases of investments		(344)		(204)		(995)
Proceeds from Sale and Maturities of Investments		295		345		721
Other investing activities - net		(3)		(1)		(7)
Cash provided by (used for) investing activities		(632)		(362)		(674)
Net Change in borrowings (less than 90 days)		(13)		13		0
Proceeds from Related Party Debt		48		52		103
Repayments of Related Party Debt		(1,422)		(1,349)		(665)
Proceeds from Debt		1,358		419		2,439
Payments on Debt		(1,140)		(421)		(1,441)
Proceeds from Exercise of Stock Options		88		100		56
Payment for acquisition of subsidiary's interest from the non-controlling interest		0		0		(60)
Other financing activities		(66)		(42)		(51)
Cash provided by (used for) financing activities		(1,147)		(1,228)		381
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents		(278)		(136)		7
Increase (decrease) on cash, cash equivalents and restricted cash		(1,218)		963		1,700
Cash, cash equivalents and restricted cash equivalents at beginning of period		4,836		3,873		2,173
Cash, cash equivalents and restricted cash equivalents at end of period		3,618		4,836		3,873
Interest, net of amounts capitalized	[2]	75		30		36
Income Taxes		467		341		229
Total company [Member]
Restructuring and asset related charges- net		363		289		335
Total company [Member] | EIDP
Restructuring and asset related charges- net		$ 363		$ 289		$ 335

[1] See page F-24 for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the Consolidated Statements of Cash Flows.

[2] Reflects interest, net of amounts capitalized, paid to external parties. For information associated with interest paid on related party debt refer to EIDP's Note 2 - Related Party Transactions, of the EIDP Consolidated Financial Statements.